Cost must not deprive brave little Anna of crucial drug
Little Co Down girl Anna Turner has a rare condition which means her bones cannot grow properly. It is a condition that could kill her - but there is a drug which can, and has, kept her alive by promoting bone growth.
Imagine the anguish of her parents, who have learned that NICE, the body overseeing spending on NHS treatments, says that the drug may soon be withdrawn because it is too expensive.
Yes, it is expensive, and NHS budgets are tight, but this is a rare case and an organisation set up to provide universal care should not equate this little girl's life to a line on a balance sheet. It must save her.